Tuberculosis trends in a hot-spot region in Paris, France von Pierre-Audigier, C., Talla, C., Alame-Emane, A-K., Audigier, B., Grall, N., Ruimy, R., Andremont, A., Cadet-Daniel, V., Sola, C., Takiff, H., Gicquel, B., Vray, M., Armand-Lefevre, L.

Volltext

Tired, angry, and unhappy with us: Poor sleep quality predicts increased anger and worsened perceptions of relationship quality von Audigier, Alexis, Glass, Sara, Slotter, Erica B., Pantesco, Elizabeth

Volltext

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT) von Barlesi, Fabrice, Dr Prof, Mazieres, Julien, Prof, Merlio, Jean-Philippe, Prof, Debieuvre, Didier, MD, Mosser, Jean, Prof, Lena, Hervé, MD, Ouafik, L'Houcine, Prof, Besse, Benjamin, MD, Rouquette, Isabelle, MD, Westeel, Virginie, Prof, Escande, Fabienne, MD, Monnet, Isabelle, MD, Lemoine, Antoinette, Prof, Veillon, Rémi, MD, Blons, Hélène, PharmD, Audigier-Valette, Clarisse, MD, Bringuier, Pierre-Paul, Prof, Lamy, Régine, MD, Beau-Faller, Michèle, MD, Pujol, Jean-Louis, Prof, Sabourin, Jean-Christophe, Prof, Penault-Llorca, Frédérique, Prof, Denis, Marc G, Prof, Lantuejoul, Sylvie, Prof, Morin, Franck, MSc, Tran, Quân, MSc, Missy, Pascale, PhD, Langlais, Alexandra, MSc, Milleron, Bernard, MD, Cadranel, Jacques, Prof, Soria, Jean-Charles, Prof, Zalcman, Gérard, Prof

Volltext

Apelin, a Newly Identified Adipokine Up-Regulated by Insulin and Obesity von Boucher, Jérémie, Masri, Bernard, Daviaud, Danièle, Gesta, Stéphane, Guigné, Charlotte, Mazzucotelli, Anne, Castan-Laurell, Isabelle, Tack, Ivan, Knibiehler, Bernard, Carpéné, Christian, Audigier, Yves, Saulnier-Blache, Jean-Sébastien, Valet, Philippe

Volltext

Apelin is a potent activator of tumour neoangiogenesis von SORLI, S. C, LE GONIDEC, S, KNIBIEHLER, B, AUDIGIER, Y

Volltext

PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic... von Blons, H., Oudart, J.-B., Merlio, J.-P., Debieuvre, D., de Fraipont, F., Audigier-Valette, C., Escande, F., Hominal, S., Bringuier, P.‐P., Fraboulet-Moreau, S., Ouafik, L., Moro-Sibilot, D., Lemoine, A., Langlais, A, Missy, P., Morin, F., Souquet, P.-J., Barlesi, F., Cadranel, J., Beau‐Faller, M.

Volltext

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC von Socinski, Mark A, Jotte, Robert M, Cappuzzo, Federico, Orlandi, Francisco, Stroyakovskiy, Daniil, Nogami, Naoyuki, Rodríguez-Abreu, Delvys, Moro-Sibilot, Denis, Thomas, Christian A, Barlesi, Fabrice, Finley, Gene, Kelsch, Claudia, Lee, Anthony, Coleman, Shelley, Deng, Yu, Shen, Yijing, Kowanetz, Marcin, Lopez-Chavez, Ariel, Sandler, Alan, Reck, Martin

Volltext

Apelin (65‐77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells von Masri, Bernard, Morin, Natacha, Cornu, Marion, Knibiehler, Bernard, Audigier, Yves

Volltext

Apelin signalling: a promising pathway from cloning to pharmacology von Masri, B., Knibiehler, B., Audigier, Y.

Volltext

Making Sense of ‘Us’: Mechanisms Linking Attachment Avoidance and Couple Identity Clarity von Slotter, Erica B., Emery, Lydia F., Audigier, Alexis, Gardner, Wendi L.

Volltext

1402P Real-world routine KRAS testing practices in France for patients (pts) with advanced or metastatic (AM) non-small cell lung cancer (NSCLC): Data from the ESME cohort von Audigier Valette, C., Pérol, M., Girard, N., Bosquet, L., De Gunten, L., Desamericq, G., Tzala, L., Allard, B., Debieuvre, D.

Volltext

The G Protein-Coupled Receptor Agtrl1b Regulates Early Development of Myocardial Progenitors von Scott, Ian C., Masri, Bernard, D'Amico, Leonard A., Jin, Suk-Won, Jungblut, Benno, Wehman, Ann M., Baier, Herwig, Audigier, Yves, Stainier, Didier Y.R.

Volltext

Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non–small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study... von Cortot, Alexis B., Audigier-Valette, Clarisse, Molinier, Olivier, Le Moulec, Sylvestre, Barlesi, Fabrice, Zalcman, Gérard, Dumont, Patrick, Pouessel, Damien, Poulet, Claire, Fontaine-Delaruelle, Clara, Hiret, Sandrine, Dixmier, Adrien, Renault, Patrick-Aldo, Becht, Catherine, Raffy, Olivier, Dayen, Charles, Mazieres, Julien, Pichon, Eric, Langlais, Alexandra, Morin, Franck, Moro-Sibilot, Denis, Besse, Benjamin

Volltext

Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 S... von Peters, S., Dafni, U., Dómine, M., Popat, S., Andrade, J., Becker, A., Moro-Sibilot, D., Curioni-Fontecedro, A., Molinier, O., Nackaerts, K., Insa Mollá, A., López Vivanco, G., Madelaine, J., Faehling, M., Griesinger, F., González Larriba, J.L., Provencio Pulla, M., Vervita, K., Roschitzki-Voser, H., Ruepp, B., Mitchell, P., Le Pechoux, C., De Ruysscher, D., Stahel, R., Hiltbrunner, A., Gasca-Ruchti, A., Giacomelli, N., Kammler, R., Marti, N., Pfister, R., Piguet, A.C., Roux, S., Troesch, S., Schweri, R., Zigomo, I., Tsourti, Z., Tsouprou, S., Kassapian, M., Vervita, K., Dimopoulou, G., Andriakopoulou, C., Morin, F., Amour, E., Mariaule, G., Archirel, N., Fernandez, M., Pereira, E., Benito, L., Lopez, K., Hernández, A., Chinchen, S., Jurkovic, H., Livingstone, A., Walker, M., Mitchell, P., Ng, S., Steer, C., Briscoe, K., Saqib, A., O’Byrne, K., Chittajallu, B.R., Hughes, B.G., Black, A., Nackaerts, K., Werner, H., Gervais, R., Zalcman, G., Monnet, I., Moro-Sibilot, D., Molinier, O., Girard, N., Souquet, P.-J., Barlesi, F., Debieuvre, D., Senellart, H., Poudenx, M., Dixmier, A., Pouessel, D., Cadranel, J., Lena, H., Quoix, E., Friard, S., Audigier-Valette, C., Mazieres, J., Pichon, E., Faehling, M., Kokowski, K., Griesinger, F., Tufman, A., de Langen, J., González Larriba, J.L., Insa, A., Massutí, B., Pulla, M.P., Aix, S.P., Villanueva, N., Andrade, J., Curioni-Fontecedro, A., Franks, K., Califano, R.

Volltext

Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous nonesmall-cell lung cancer: Results of the IFCT-1103 ULTIMATE study von Cortot, Alexis B., Audigier-Valette, Clarisse, Molinier, Olivier, Le Moulec, Sylvestre, Barlesi, Fabrice, Zalcman, Gerard, Dumont, Patrick, Pouessel, Damien, Poulet, Claire, Fontaine-Delaruelle, Clara, Hiret, Sandrine, Dixmier, Adrien, Renault, Patrick-Aldo, Becht, Catherine, Raffy, Olivier, Dayen, Charles, Mazieres, Julien, Pichon, Eric, Langlais, Alexandra, Morin, Franck, Moro-Sibilot, Denis, Besse, Benjamin

Volltext

EVIDENS: An observational study of nivolumab-treated patients in advanced non-small cell lung cancer (NSCLC) in a real-world setting: Initial results on 1394 patients von Dixmier, A., Debieuvre, D., Raspaud, C., Auliac, J.B., Benoit, N., Bombaron, P., Asselain, B., Dumont, A., Lamoureux, P., Goyard, N., Moro-Sibilot, D., Perol, M., Barlesi, F., Audigier Valette, C.

Volltext

Real-world treatment patterns, clinical practice and outcomes for locally advanced, non resectable, non-small cell lung cancer from the French ESME Lung database von Girard, N., Pérol, M., Simon, G., Audigier Valette, C., Gervais, R., Debieuvre, D., Schott, R., Quantin, X., Coudert, B., Lena, H., Carton, M., Robain, M., Filleron, T., Chouaid, C.

Volltext

Health-related quality of life (HRQoL) of non-small cell lung cancer (NSCLC) patients treated with nivolumab in real-life: The EVIDENS study von Pérol, M., Dixmier, A., Barlesi, F., Debieuvre, D., Raspaud, C., Auliac, J.B., Benoit, N., Bombaron, P., Moro-Sibilot, D., Asselain, B., Cotté, F.-E., Lamoureux, P., Karam, N., Ozan, N., Calvet, C., Bryan, B., Allan, V., Audigier Valette, C.

Volltext

Love's a dance you learn as you go: Evidence for interpersonal complementarity during romantic conflict and its association with relationship outcomes von Slotter, Erica B., Markey, Patrick M., Audigier, Alexis, Dashineau, Samantha C., Finkel, Eli J., Luchies, Laura B.

Volltext

MO1-1 6y update of 1L nivolumab + ipilimumab (N+I) in metastatic (m) NSCLC, including in Japanese pts, from CheckMate 227 von Nishio, M., Ramalingam, S.S., Ciuleanu, T., Caro, R. Bernabe, Mizutani, H., Lee, J., Audigier-Valette, C., Sangha, R., Urban, L., Burgers, J.A., Pluzanski, A., Lee, K. Hyeong, Zurawski, B., Schenker, M., Peters, S., Paz-Ares, L.G., Borghaei, H., O'Byrne, K.J., Brahmer, J.R., Gupta, R.G., Bushong, J., Li, L., Yuan, Y., Blum, S.I., Reck, M.

Volltext